Results 281 to 290 of about 72,862 (382)

The Use of CRISPR-Cas9 Genetic Technology in Cardiovascular Disease: A Comprehensive Review of Current Progress and Future Prospective. [PDF]

Cureus
Asif M, Khan WJ, Aslam S, Aslam A, Chowdhury MA.   +4 more
europepmc   +1 more source

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow, Robert S. Croop, Alexandra Thiry, Richard B. Lipton   +3 more
wiley   +1 more source

Benefits of Integrated Social Care in the Management of Patients With Inborn Errors of Metabolism. [PDF]

JIMD Rep
Selvanathan A, Nazir S, van Wyk K, Simpson E, Holmes V, Hutton R, White F, Schwahn BC.   +7 more
europepmc   +1 more source

Symposium on recent trend in the research of hyperlipidemia in Japan. Supplement. Influence of defective metabolism of low-density lipoprotein on atherosclerosis.

, 1989
Kenji Ishii, Toru Kita
openalex   +2 more sources

Statin-Intolerant Patients Exhibit Diminished Muscle Strength Regardless of Lipid-Lowering Therapy. [PDF]

J Clin Med
Vinci P, Di Girolamo FG, Pellicori F, Panizon E, Pirulli A, Tosoni LM, Altamura N, Rizzo S, Perin A, Fiotti N, Biolo G.   +10 more
europepmc   +1 more source

Symposium on recent trend in the research of hyperlipidemia in Japan. Supplement. Physical exercise in the treatment of hyperlipidemia.

, 1989
Toshitaka TAMAI, Tsuguhiko NAKAI
openalex   +2 more sources

Dyslipidaemia in endocrine disorders. [PDF]

Indian Heart J
Sridharan K, Kalra S.
europepmc   +1 more source

The Effects of Drug Therapy on Hyperlipidemia

, 1989
Mitsunobu Kawamura, Hiroo Ito, Chikayuki NAITO   +2 more
openalex   +2 more sources

Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The majority of patients with essential thrombocythemia (ET) show somatic mutations of JAK2, CALR, or MPL. Around 10% of cases lack these mutations (“triple negative” ET, TN‐ET). Additionally, some patients with bona fide “primary thrombocytosis” (PT) [i.e., high platelet (PLT)‐ count with no apparent underlying causes] do not ...
Valentina Sangiorgio, Federica Mottadelli, Fabio Pagni, Fabrizio Cavalca, Giovanni Cazzaniga, Martina Venegoni, Carlo Gambacorti‐Passerini, Rocco Piazza, Elena Maria Elli   +8 more
wiley   +1 more source

Effect of Combined Therapy with Clinofibrate and Melinamide on Serum Lipid in Type IIa Hyperlipidemia

, 1987
Hiromi Tasaki, Akira Yashiro, Masahiro Sugano, Chizuko Ooba, Yasuhide Nakashima, Akio Kuroiwa   +5 more
openalex   +2 more sources